Editor: Atta-ur-Rahman

Frontiers in Clinical Drug Research – Diabetes and Obesity

Volume 5

eBook: US $69 Special Offer (PDF + Printed Copy): US $117
Printed Copy: US $83
Library License: US $276
ISSN: 2467-9607 (Print)
ISSN: 2352-3220 (Online)
ISBN: 978-1-68108-754-2 (Print)
ISBN: 978-1-68108-753-5 (Online)
Year of Publication: 2020
DOI: 10.2174/97816810875351190501


Frontiers in Clinical Drug Research – Diabetes and Obesity is a book series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of two metabolic diseases – diabetes and obesity. The scope of the series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of natural and synthetic drugs affecting endocrine and metabolic processes linked with diabetes and obesity. Reviews in this series also include research on specific receptor targets and pre-clinical / clinical findings on novel pharmaceutical agents. Frontiers in Clinical Drug Research – Diabetes and Obesity is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in the field of diabetes and obesity research.

The fifth volume of this series features 5 reviews which are informative guides to therapy and drug administration in diabetes and metabolic syndrome, for both the medical specialist and the pharmacologist.

-Metabolic syndrome in schizophrenia

-Insulin therapy and foetoplacental endothelial dysfunction in gestational diabetes mellitus

-Insights on diabetes, oxidative stress and antioxidant therapeutic strategies

-Administration of nano drugs in the treatment of diabetes mellitus

-SGLT-2 inhibitors


- Pp. i
Download Free

List of Contributors

- Pp. ii-iii (2)
Download Free

Metabolic Syndrome in Schizophrenia: Focus on the Role of Antipsychotic Medications and Indications for Therapeutic Drug Monitoring (TDM) Methods

- Pp. 1-65 (65)
Roberto Mandrioli, Michele Protti, Laura Mercolini
View Abstract

Insulin Therapy and Foetoplacental Endothelial Dysfunction in Gestational Diabetes Mellitus

- Pp. 66-86 (21)
Mario Subiabre, Roberto Villalobos-Labra, Luis Silva, Fabián Pardo, Luis Sobrevia
View Abstract

Insights on Diabetes, Oxidative Stress and Antioxidant Therapeutic Strategies

- Pp. 87-115 (29)
Nicolette Nadene Houreld, Naresh Kumar Rajendran
View Abstract

Administration of Nano Drugs in the Treatment of Diabetes Mellitus

- Pp. 116-137 (22)
Radhika Tippani, Rama Narsimha Reddy Anreddy, Mahendar Porika
View Abstract

SGLT-2 Inhibitors: An Evidence-Based Perspective

- Pp. 138-155 (18)
Siddhartha Dutta, Pramod Kumar Sharma, Arup Kumar Misra
View Abstract

Subject Index

- Pp. 156-165 (10)
Download Free


.Natural Products in Clinical Trials.
.Good Quality Practice (GQP) in Pharmaceutical Manufacturing: A Handbook.
.Natural Products in Clinical Trials.
.Advances in Physicochemical Properties of Biopolymers: Part 1.